The page is the record's research on the issuer — no analyst, no rating, no view.

Biovica International AB ser. B (SE0008613731) — research page

SE · se-cm-kg/SSME/SE0008613731 · as of 2026-11-06

Identity and listing

Biovica International AB ser. B is listed on First North Sweden under the ticker SE0008613731. Its ISIN is SE0008613731 and its LEI is 549300VADE1VRR555N78. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.

fieldvaluesource · read date
nameBiovica International AB ser. Bsource · 2026-11-06
exchangeFirst North Swedensource · 2026-11-06
tickerSE0008613731source · 2026-11-06
ISINSE0008613731source · 2026-11-06
LEI549300VADE1VRR555N78source · 2026-11-09
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 43 filings across 35 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7.0 days. Days from the latest filing to the record date is 14. The latest filing is dated 2026-10-23 and is a Company Announcement. The First North Sweden median cadence gap is 11.0 days, the median filings are 21 and the median latency is 7 days, across 325 issuers. The sector median is not on the record.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer43714
exchange median: First North Sweden (325 issuers)21117
datetypecategoryfiling
2026-10-23Company AnnouncementCompany AnnouncementBiovica announces outcome of the rights issue
2026-10-12Company description / prospectusCompany description / prospectusCorrection: Biovica clarifies the description of its patent position in the share issue memorandum published on Oct 6, 2026
2026-10-06Company description / prospectusCompany description / prospectusBiovica publishes share issue memorandum in connection with the rights issue
2026-10-06Investor NewsInvestor NewsBiovica announces change in Pharma Services leadership as it strengthens its Pharma offering
2026-09-30Decisions of general meetingDecisions of general meetingAnnouncement from the extra general meeting in Biovica International AB

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and neither is its location. The record does not carry auditor changes for this register.

Events and halts

The record does not carry listing, delisting, name change, domicile change or segment move dates for this register. The halt flag is listed, not halted.

Orderability

The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1 because the chapter's orderability section carries no client categories. The chapter is as of 2026-11-04.

rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names one research house, REDEYE.

research houseanalystsource · read date
REDEYEFilip Lindkvistissuer page · 2026-11-12

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://firds.esma.europa.eu/firds/ (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.3
https://mcp.se-cm-kg.ai/events/SSME/SE0008613731 (the disclosure lines)
10.4
https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
10.5
https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://biovica.com/investor-relations/the-share/analyst-coverage/ (coverage)
10.7
https://mcp.se-cm-kg.ai/record/SSME/SE0008613731 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0008613731"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:3f15d7fa2103fac6.